Ensysce Biosciences, Inc. (ENSC)
Last updated: 2026-10-21 14:57:00. Prices reflect the latest regular market data. Stock price data is sourced from Massive.
Summary
Ensysce Biosciences, Inc. (ENSC) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $0.51, with a market capitalization of $9.78M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $0.23 to $2.57. This page covers its latest market performance, valuation, price trends and company information.
Key Market Data
$9.78M | |
$0.49 | |
$61,632.00 | |
$0.23 | |
$0.50 | |
142.42K | |
14.19M | |
-- | |
$2.57 | |
$0.23 | |
-- | |
-- |
Ensysce Biosciences, Inc. (ENSC) Stock Price Today
Ensysce Biosciences, Inc. (ENSC) is currently trading at $0.51 as of 2026-10-21 14:55:00, up 2.29% ($0.01) from the previous close of $0.50
During today's regular trading session, ENSC has traded between $0.23 and $61,632.00, with a trading volume of 142.42K shares. The current price is near the lower end of today's range.
Ensysce Biosciences, Inc. (ENSC) 7-Day Stock Price Change
Over the past seven days, Ensysce Biosciences, Inc. (ENSC) moved from $0.56 to $0.51, representing a decline of 8.26% ($0.05).
The stock traded between $0.49 and $0.62 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.
The average daily volume was 616.43 thousand shares, down versus the previous seven-day period, indicating lower trading activity.
ENSC 52-Week Price Position
Position in Range: 12.0%
ENSC is currently trading at $0.51, placing it 12.0% of the way from its 52-week low of $0.23 to its 52-week high of $2.57. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
What is Ensysce Biosciences, Inc. (ENSC)?
Ensysce Biosciences Inc is a clinical-stage biotech company using its proprietary technology platforms to develop safer prescription drugs. The company is developing a new class of powerful, opioids that prevent both drug abuse and overdoses. Its products are anticipated to provide safer options to treat severe pain and assist in preventing deaths caused by opioid abuse, reducing human and economic costs. The company's current development pipeline includes two new drug platforms: an abuse-resistant opioid prodrug technology, theTrypsin Activated Abuse Protection, or the TAAP platform, and an over-dose protection opioid prodrug technology, the Multi-Pill Abuse Resistant, or the MPAR platform. The Company currently operates in one business segment, which is pharmaceuticals.
Ensysce Biosciences, Inc. Information
| Industry | PHARMACEUTICAL PREPARATIONS |
| Employees | 10 |
| Exchange | NASDAQ |
| Company Website |
How to Buy Ensysce Biosciences, Inc. (ENSC) Stock on MEXC
Eligible investors can buy real shares of Ensysce Biosciences, Inc. (ENSC) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Frequently Asked Questions (FAQ)
1.What is Ensysce Biosciences, Inc. (ENSC) stock price today?
2.Is ENSC stock going up or down today?
3.What is ENSC pre-market price?
4.What is ENSC after-hours price?
5.Is ENSC stock trading now?
6.Where does ENSC sit relative to its 52-week high and low?
7.What sector is Ensysce Biosciences, Inc. in?
8.What is Ensysce Biosciences, Inc.'s market capitalization and where is it listed?
9.How is ENSC valued in terms of P/E ratio and EPS?
10.Does Ensysce Biosciences, Inc. pay a dividend?
Explore More US Stocks
Search Stocks
ENSC Stock Calculator
Estimate the value between ENSC shares and USD.
ENSC Shares to USD
1.00 ENSC shares = 0.51 USD
Calculations are estimates based on the latest available price and are for reference only.



